Ethopropazine
Based on 1 publication(s) in Google Scholar
Ethopropazine (Isothazine) is a potent and selective BChE inhibitor, a poor AChE inhibitor and a non-selective mAChR and NMDA antagonist. Ethopropazine has anticholinergic, antihistamine, antiadrenergic actions and properties. Ethopropazine alleviates thermal hyperalgesia in a dose dependent manner. Ethopropazine can be used for the research of Parkinson’s disease.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- CAS. Nr.: 522-00-9
- Formel: C19H24N2S
- Molecular Weight:312.48
-
Speicherung:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) Ethopropazine
MoreAlle iGluR Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Beschreibung
IC50 & Target
|
AChE |
BChE |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HEK293 | IC50 |
20.46 μM
Compound: Ethopropazine
|
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay
Inhibition of human OCT1 expressed in HEK293 cells assessed as decrease in uptake of ASP+ after 2 mins by fluorescence assay
|
[PMID: 28230985] |
| NCI-H1650 | GI50 |
>40 μM
Compound: Ethopropazine
|
Cytotoxicity against human NCI-H1650 cells assessed as growth inhibition after 48 hrs by MTT assay
Cytotoxicity against human NCI-H1650 cells assessed as growth inhibition after 48 hrs by MTT assay
|
[PMID: 26372073] |
In Vitro
Ethopropazine (0-250 µM, 24 h) exhibits dose-dependent toxicity in LAN-5 cells with an LD50 of 28 µM[1].
Ethopropazine (<28 µM, 24 h) exhibits proliferative properties in SK-N-SH cells by enhancing [3H] thymidine uptake[1].
Ethopropazine (10 μM, 24 h) significantly enhances the proliferation of NCI-H69 cells, and this proliferative effect is significantly inhibited by the mAChR3 antagonist 4-DAMP (HY-100958)[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Adult female Sprague-Dawley rats (weight 300-330 g) underwent loose ligation of the right sciatic nerve to induce thermal hyperalgesia (neuropathic pain)[1]
-
Dosage:10, 20, 30 mg/kg combined with 0.025 mg/kg Clonidine (HY-12721) or 0.1 mg/kg Guanabenz (HY-12724)
-
Administration:Subcutaneous administration for a single dose
-
Result:Showed no significant effect on pawwithdrawal latency (PWL) in either ligated or unligated limbs at 10 mg/kg.
Increased PWL in the ligated limb significantly at 1 hour post-administration at 20 mg/kg.
Increased PWL in the ligated limb at 1, 2, and 3 hours post-administration at 30 mg/kg.
Increased PWL in the ligated limb at 1-2 hours post-administration when combined with 0.025 mg/kg Clonidine.
Increased PWL in the ligated limb at 1-3 hours post-administration when combined with 0.1 mg/kg Guanabenz.
Chemical Information
-
CAS. Nr. 522-00-9
-
Molecular Weight 312.48
-
Formel C19H24N2S
-
SMILES
S1C=2C=CC=CC2N(C=3C=CC=CC13)CC(N(CC)CC)C
-
Synonyms
Isothazine free base
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (1)
-
Journal Impact Factor
-
Most Recent
Reinheit & Dokumentation
Verweise
[1]. Giladi N, et al. Toxicity of the specific antimuscarinic agent methoctramine and other non-specific anticholinergic drugs in human neuroblastoma cell lines in vitro. Toxicol In Vitro. 1993 Sep;7(5):595-603. [Content Brief]
[2]. Inazu M, et al. Functional expression of choline transporter-like protein 1 (CTL1) in small cell lung carcinoma cells: a target molecule for lung cancer therapy. Pharmacol Res. 2013 Oct;76:119-31. [Content Brief]
[3]. Jevtovic-Todorovic V, et al. Anti-parkinsonian agents procyclidine and ethopropazine alleviate thermal hyperalgesia in neuropathic rats. Neuropharmacology. 2003 May;44(6):739-48. [Content Brief]
[4]. Sinko G, et al. Mechanism of stereoselective interaction between butyrylcholinesterase and ethopropazine enantiomers. Biochimie. 2011 Oct;93(10):1797-807. [Content Brief]
[5]. V. Debbeti, et al. Transition Metal Complexes of Ethopropazine: Synthesis and Characterization
Calculators
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)